COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study
CONCLUSION: Patients with GCA/PMR were more likely to have severe COVID-19 and higher mortality compared to those with RA. This worse prognosis is mostly due to well known risk factors for the general population rather than vasculitis per se.PMID:35926375 | PMC:PMC9296684 | DOI:10.1016/j.jaut.2022.102868
Source: Journal of Autoimmunity - Category: Allergy & Immunology Authors: Matheus Vieira Clo é Comarmond Julien Labreuche Adrien Mirouse David Saadoun Christophe Richez Ren é-Marc Flipo Eric Hachulla Elodie Drumez Patrice Cacoub FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors Source Type: research
More News: Allergy & Immunology | Arthritis | Cardiology | Cardiovascular | COVID-19 | Diabetes | Endocrinology | France Health | Heart | Hypertension | Polymyalgia Rheumatica | Rheumatoid Arthritis | Rheumatology | Rituxan | Study | Vasculitis